VEGFC and lung cancer: Additionally, there was a significant difference at the RTduring time point in the concentrations of sFLT-1 (p = 0.03) and VEGF-C (p = 0.005) and VEGF-C at RTend (p = 0.04) between esophageal and lung cancer patients, but not in any other chemokines.